Key stats
About MEDIPRESS HEALTH-L
Sector
Industry
Headquarters
Ramat Gan
ISIN
IL0011828980
FIGI
BBG0147JKT05
Medipress Health-LP engages in research and development. It operates in the field of medical equipment, digital medicine, including digital solutions in the field of artificial intelligence (AI) in the world of medicine, and in the field of remote diagnostic treatment. The company was founded on March 25, 2021 and is headquartered in Ramat Gan, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MPRS is 78.0 ILA — it has decreased by −0.97% in the past 24 hours. Watch MEDIPRESS HEALTH-L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange MEDIPRESS HEALTH-L stocks are traded under the ticker MPRS.
MPRS reached its all-time high on Jul 1, 2021 with the price of 971.2 ILA, and its all-time low was 40.8 ILA and was reached on Feb 9, 2023. View more price dynamics on MPRS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MPRS stock is 7.11% volatile and has beta coefficient of 0.16. Track MEDIPRESS HEALTH-L stock price on the chart and check out the list of the most volatile stocks — is MEDIPRESS HEALTH-L there?
No, MPRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MPRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPRESS HEALTH-L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPRESS HEALTH-L technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPRESS HEALTH-L stock shows the sell signal. See more of MEDIPRESS HEALTH-L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.